Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study

Study limitation reported by the research below: “This is a real-world clinical cohort without randomisation; confounding by indication and co-morbidities cannot be fully excluded.”